Evidence map›Paper›PMID 41813009›Full record

ReviewPediatric dermatology

NEMO-NDAS: Case Report and Review of the Literature.

Angela Yang, Kristie Mar, Kimberly A Morishita, Kevin Meesters, Antonio Torrelo, Joseph M Lam

Abstract readCase ReportsReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pediatric dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Angela YangFaculty of Science, University of British Columbia, Vancouver, British Columbia, Canada.ORCID https://orcid.org/0009-0006-6744-3035
Kristie MarFaculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.ORCID https://orcid.org/0000-0002-2482-8633
Kimberly A MorishitaDepartment of Paediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
Kevin MeestersDepartment of Paediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
Antonio TorreloDepartment of Dermatology, Hospital Infantil Niño Jesús, Madrid, Spain.ORCID https://orcid.org/0000-0002-5940-6916
Joseph M LamDepartment of Paediatrics, University of British Columbia, Vancouver, British Columbia, Canada.ORCID https://orcid.org/0000-0001-7808-3369

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NEMO-deleted exon 5 autoinflammatory syndrome (NEMO-NDAS) is the result of a gain-of-function IKBKG pathogenic variant leading to dysregulated NF-κB signaling and systemic inflammation. We present a case of NEMO-NDAS in a 2-year-old female presenting with recurrent fevers, subcutaneous nodules, lymphadenopathy, and splenomegaly. This article highlights the symptoms that aid in diagnosis and how to differentiate it from other autoinflammatory diseases and reviews therapies for NEMO-NDAS.

Indexed as

Hereditary Autoinflammatory DiseasesI-kappa B KinaseChild, PreschoolDiagnosis, DifferentialFemaleHumansI-kappa B KinaseIKBKG protein, human

Identifiers

PMID41813009
PMCPMC13422992

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.